Summit Therapeutics (SMMT) Other Working Capital Changes (2019 - 2026)

Summit Therapeutics (SMMT) has reported Other Working Capital Changes for 9 consecutive years, with $3000.0 the latest figure, recorded in Q2 2026.

• Quarterly Other Working Capital Changes fell 88.89% year-over-year to $3000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$2000.0 (down 100.5% YoY) and the FY2025 annual result came in at $80000.0, down 15.79% from the prior year.
• Other Working Capital Changes improved to $3000.0 in Q2 2026 per SMMT's latest filing, from -$33000.0 in the prior quarter.
• Over the last five years, Other Working Capital Changes for SMMT reached as high as $12.0 million in Q2 2026 and fell as low as -$7.0 million in Q4 2023.
• A 5-year average of $1.5 million and a median of $705000.0 in 2022 frame the typical range for Other Working Capital Changes.
• Annual changes were most pronounced in 2022 — Other Working Capital Changes sank 1669.72% — and 2024, when it surged 455.17%.
• Year by year, Other Working Capital Changes stood at $276000.0 in 2022, then slumped by 121.01% to -$58000.0 in 2023, then soared by 143.1% to $25000.0 in 2024, then plunged by 108.0% to -$2000.0 in 2025, then jumped by 250.0% to $3000.0 in 2026.
• According to Business Quant data, Other Working Capital Changes over the past three periods registered $3000.0, -$33000.0, and -$2000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.